$MGT, http://sharemarketupdates.com/wp-content/up

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz
$MGT,
SEO-Talent-vs-Technology.jpg
Projecting The Future
Projecting The Future
Tech Stocks in the Rumor: MGT Capital Investments Inc. (NYSEMKT:MGT), Bazaarvoice Inc (NASDAQ:BV)

Posted by: Anthony Davis in Technology June 20, 2016 0 93 Views

Shares of MGT Capital Investments Inc. (NYSEMKT:MGT) ended Friday session in green amid volatile trading. The shares closed up +0.01 points or 0.29% at $3.45 with 8.35 million shares getting traded. Post opening the session at $3.73, the shares hit an intraday low of $3.22 and an intraday high of $3.73 and the price vacillated in this range throughout the day. The company has a market cap of $82.34 million and the numbers of outstanding shares have been calculated to be 23.80 million shares.

MGT Capital Investments Inc. (MGT) on June 17, 2016 announced the appointment of Steve Orenberg, a long-time executive in the Internet and cyber security industry, as the Chairman of the Company’s newly formed Emerging Large Scale Technology Advisory Board (ELSTAB), effective immediately.

Orenberg is currently serving as the President and CEO of EdgeWave, a cyber security company delivering innovative, effective and efficient security solutions across the full spectrum of business and government organizations. Most notably, Orenberg spent the past 10 years as the President of Kaspersky Lab, Inc., where he founded the company’s North American operation and grew it into a $160 million plus concern. Orenberg’s leadership grew Kaspersky into the position of number one vendor partner in corporate and government enterprise client security software. Previously, Orenberg was President of the internet security companies Sophos, Inc., NetGuard and Dr. Solomon’s Software, which was acquired by Network Associates (now Intel Security) in 1998.

“Steve is exactly the person I have been looking for to advise us on the intricate field of securing critical large scale cyber systems and their increasing connection to, and dependence on mobile devices. Steve and I both understand that the anti-virus paradigm is finished and that a new paradigm must be developed,” said John McAfee, proposed Executive Chairman and Chief Executive Officer of MGT Capital. “We are honored that Steve has agreed to head up our new ELSTAB.”

Shares of Bazaarvoice Inc (NASDAQ:BV) ended Friday session in green amid volatile trading. The shares closed up +0.01 points or 0.29% at $3.48 with 7,956,510 shares getting traded. Post opening the session at $3.49, the shares hit an intraday low of $3.40 and an intraday high of $3.62 and the price vacillated in this range throughout the day. The company has a market cap of $286.43 million and the numbers of outstanding shares have been calculated to be 82.07 million shares.

Bazaarvoice Inc (BV) on June 02, 2016 reported its financial results for the fourth fiscal quarter and full year ended April 30, 2016.

“We delivered our third consecutive quarter of positive adjusted EBITDA and positive operating cash flow for the fiscal fourth quarter,” said Gene Austin, chief executive officer and president. “Fiscal 2016 was a pivotal year for Bazaarvoice as we launched a number of new initiatives to position the company for long term growth while simultaneously driving improved operating margin performance. We are uniquely positioned with our broad Consumer Generated Content offerings and shopper advertising and additional solutions to further monetize our network of retailers and brands.”

Fourth Fiscal Quarter of 2016 Financial Details

Revenue from continuing operations: Bazaarvoice reported revenue of $50.7 million for the fourth fiscal quarter of 2016, up 5.0% from the fourth fiscal quarter of 2015, which consisted of SaaS revenue of $49.1 million and net advertising revenue, formerly referred to as media revenue, of $1.6 million.

GAAP net loss and net loss per share from continuing operations: GAAP net loss was $6.4 million, compared to a GAAP net loss of $8.8 million for the fourth fiscal quarter of 2015. GAAP net loss per share was $0.08 based upon weighted average shares outstanding of 81.5 million, compared to GAAP net loss per share of $0.11 for the fourth fiscal quarter of 2015 based upon weighted average shares outstanding of 79.7 million.
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 1

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 2

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
See's Candies Data Breach Spurs Legal Scrutiny

Updated Category News Views 12

Data Breach Hits See's Candies Hard Amidst Ransomware Attack Alright, folks, here's a not-so-sweet tale to kick off your day — See's Candies has found itself in a bit of a pickle. A ransomware attack, the nasty kind that makes you double-check your locks and your passwords, has reportedly exposed the personal data of its customers and employees. We're talking names,...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 7

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
Media Forum Spotlights Asia-Pacific Cooperation

Updated Category News Views 3

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 3

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 3

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover Space-ng's New Computer Vision Solutions

Updated Category News Views 125

Introducing Space-ng's Innovative Vision System Space-ng is excited to present a revolutionary Hardware Development Kit (HDK) and a Software Development Kit (SDK) tailored for their renowned Sol3 Vision System. This initiative embodies a commitment to affordable, rugged, and air-cooled technology suitable for space applications. The HDK is designed for rapid prototyping,...

Continue Reading
iOnctura Advances Treatment Options for Uveal Melanoma Patients

Updated Category News Views 182

iOnctura Reports Significant Clinical Progress in Uveal Melanoma iOnctura, a clinical-stage biopharmaceutical company, has recently unveiled critical advancements in its efforts to combat uveal melanoma, a rare form of eye cancer that often presents significant treatment challenges. The company has completed its Phase I DIONE-01 study, showcasing encouraging clinical...

Continue Reading
Spyre Therapeutics Progresses with SPY001 for IBD Treatment

Updated Category News Views 115

Spyre Therapeutics Reports Encouraging Phase 1 Trial Data Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company, has recently released promising interim results from its Phase 1 trial of SPY001, an innovative half-life extended monoclonal antibody aimed at treating inflammatory bowel disease (IBD). The study indicates that SPY001 was well...

Continue Reading
Understanding the University of Phoenix Tuition Guarantee

Updated Category News Views 194

Understanding the University of Phoenix Tuition Guarantee Fixed tuition and new transparency initiatives support adult learners in planning educational expenses. University of Phoenix is enhancing its commitment to clear and consistent tuition costs through its Tuition Guarantee initiative. This program ensures that students benefit from a locked-in tuition rate from the...

Continue Reading
Halper Sadeh Investigates Shareholder Rights for IPXX, PWUP, DECA, TTNP

Updated Category News Views 38

Halper Sadeh LLC Investigates Shareholder Rights Halper Sadeh LLC, a law firm dedicated to protecting investor rights, is currently examining several companies for potential violations of federal securities laws and breaches of fiduciary duties. This investigation focuses on significant firms involved in mergers, with the aim of safeguarding shareholder interests....

Continue Reading